These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26831194)

  • 21. The cofilin phosphatase slingshot homolog 1 restrains angiotensin II-induced vascular hypertrophy and fibrosis in vivo.
    Williams HC; Ma J; Weiss D; Lassègue B; Sutliff RL; San Martín A
    Lab Invest; 2019 Mar; 99(3):399-410. PubMed ID: 30291325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
    Takayanagi T; Kawai T; Forrester SJ; Obama T; Tsuji T; Fukuda Y; Elliott KJ; Tilley DG; Davisson RL; Park JY; Eguchi S
    Hypertension; 2015 Jun; 65(6):1349-55. PubMed ID: 25916723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.
    Graciano ML; Nishiyama A; Jackson K; Seth DM; Ortiz RM; Prieto-Carrasquero MC; Kobori H; Navar LG
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F161-9. PubMed ID: 17989111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling.
    Di Zhang A; Nguyen Dinh Cat A; Soukaseum C; Escoubet B; Cherfa A; Messaoudi S; Delcayre C; Samuel JL; Jaisser F
    Hypertension; 2008 Dec; 52(6):1060-7. PubMed ID: 18981328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
    Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
    Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
    Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals.
    Kazama K; Anrather J; Zhou P; Girouard H; Frys K; Milner TA; Iadecola C
    Circ Res; 2004 Nov; 95(10):1019-26. PubMed ID: 15499027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasticity of cerebral microvascular structure and mechanics during hypertension and following recovery of arterial pressure.
    Sabharwal R; Chapleau MW; Gerhold TD; Baumbach GL; Faraci FM
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1108-H1117. PubMed ID: 36269650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent agonist-induced vasoconstriction is not required for angiotensin II to mediate inward remodeling of isolated arterioles with myogenic tone.
    Martinez-Lemus LA
    J Vasc Res; 2008; 45(3):211-21. PubMed ID: 18087168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of angiotensin II type 1 receptor subtypes within the cerebral microvasculature.
    Yamasaki E; Thakore P; Krishnan V; Earley S
    Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H461-H469. PubMed ID: 31886721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of IFN-γ in regulating OPN/Th17 pathway during vascular collagen remodeling of hypertension induced by ANG II.
    Jiang L; He P; Liu Y; Chen J; Wei X; Tan N
    Int J Clin Exp Pathol; 2015; 8(11):14433-40. PubMed ID: 26823760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. γδ T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Caillon A; Mian MOR; Fraulob-Aquino JC; Huo KG; Barhoumi T; Ouerd S; Sinnaeve PR; Paradis P; Schiffrin EL
    Circulation; 2017 May; 135(22):2155-2162. PubMed ID: 28330983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide deficiency and increased adenosine response of afferent arterioles in hydronephrotic mice with hypertension.
    Carlström M; Lai EY; Steege A; Sendeski M; Ma Z; Zabihi S; Eriksson UJ; Patzak A; Persson AE
    Hypertension; 2008 May; 51(5):1386-92. PubMed ID: 18391091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caveolin-1 limits the contribution of BK(Ca) channel to EDHF-mediated arteriolar dilation: implications in diet-induced obesity.
    Feher A; Rutkai I; Beleznai T; Ungvari Z; Csiszar A; Edes I; Bagi Z
    Cardiovasc Res; 2010 Sep; 87(4):732-9. PubMed ID: 20299334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTEN (Phosphatase and Tensin Homolog) Protects Against Ang II (Angiotensin II)-Induced Pathological Vascular Fibrosis and Remodeling-Brief Report.
    Lu S; Strand KA; Mutryn MF; Tucker RM; Jolly AJ; Furgeson SB; Moulton KS; Nemenoff RA; Weiser-Evans MCM
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):394-403. PubMed ID: 31852223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of vasoactive peptide intermedin in vascular collagen remodeling during angiotensin II-induced hypertention.
    Li JD; An WS; Xu Y; Zhao XX; Li ZF; Mu Y; Jing LS
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5652-5658. PubMed ID: 30229842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.